Synonyms: L-627 | LJC10,627 | Omegacin® | RPX2003
biapenem is an approved drug
Compound class:
Synthetic organic
|
|
References |
1. Hikida M, Kawashima K, Nishiki K, Furukawa Y, Nishizawa K, Saito I, Kuwao S. (1992)
Renal dehydropeptidase-I stability of LJC 10,627, a new carbapenem antibiotic. Antimicrob Agents Chemother, 36 (2): 481-3. [PMID:1605616] |
2. Petersen PJ, Jacobus NV, Weiss WJ, Testa RT. (1991)
In vitro and in vivo activities of LJC10,627, a new carbapenem with stability to dehydropeptidase I. Antimicrob Agents Chemother, 35 (1): 203-7. [PMID:1901698] |
3. Sharma R.
BDR Pharma gets DCGI nod for generic antibiotic drug biapenem. Accessed on 03/06/2022. Modified on 03/06/2022. Medical Dialogues, https://medicaldialogues.in/news/industry/pharma/bdr-pharma-gets-dcgi-nod-for-generic-antibiotic-drug-biapenem-82384 |
4. Ubukata K, Hikida M, Yoshida M, Nishiki K, Furukawa Y, Tashiro K, Konno M, Mitsuhashi S. (1990)
In vitro activity of LJC10,627, a new carbapenem antibiotic with high stability to dehydropeptidase I. Antimicrob Agents Chemother, 34 (6): 994-1000. [PMID:2203313] |